[go: up one dir, main page]

FI914409L - Kalciumupptagande inhibitorer. - Google Patents

Kalciumupptagande inhibitorer. Download PDF

Info

Publication number
FI914409L
FI914409L FI914409A FI914409A FI914409L FI 914409 L FI914409 L FI 914409L FI 914409 A FI914409 A FI 914409A FI 914409 A FI914409 A FI 914409A FI 914409 L FI914409 L FI 914409L
Authority
FI
Finland
Prior art keywords
uptagande
inhibitorer
calcium
uptagande inhibitorer
calcium uptagande
Prior art date
Application number
FI914409A
Other languages
English (en)
Other versions
FI914409A0 (fi
FI914409A7 (fi
Inventor
Robert Joseph Dinerstein
Michael Louis Edwards
David Martin Stemerick
Keith Allen Diekema
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI914409A0 publication Critical patent/FI914409A0/fi
Publication of FI914409L publication Critical patent/FI914409L/fi
Publication of FI914409A7 publication Critical patent/FI914409A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/08Preparation by ring-closure
    • C07D213/09Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles
    • C07D213/10Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles from acetaldehyde or cyclic polymers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
FI914409A 1990-09-20 1991-09-19 Kalsiuminoton inhibiittoreita FI914409A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58541290A 1990-09-20 1990-09-20

Publications (3)

Publication Number Publication Date
FI914409A0 FI914409A0 (fi) 1991-09-19
FI914409L true FI914409L (fi) 1992-03-21
FI914409A7 FI914409A7 (fi) 1992-03-21

Family

ID=24341317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914409A FI914409A7 (fi) 1990-09-20 1991-09-19 Kalsiuminoton inhibiittoreita

Country Status (19)

Country Link
US (1) US5500429A (fi)
EP (1) EP0476646B1 (fi)
JP (1) JP3031766B2 (fi)
KR (1) KR100198040B1 (fi)
CN (1) CN1063685A (fi)
AT (1) ATE154011T1 (fi)
AU (1) AU653957B2 (fi)
CA (1) CA2051494C (fi)
DE (1) DE69126392T2 (fi)
ES (1) ES2106042T3 (fi)
FI (1) FI914409A7 (fi)
HU (1) HUT59099A (fi)
IE (1) IE913300A1 (fi)
IL (1) IL99515A0 (fi)
NO (1) NO913684L (fi)
NZ (1) NZ239864A (fi)
PT (1) PT99011A (fi)
TW (1) TW205548B (fi)
ZA (1) ZA917371B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2051504C (en) * 1990-09-20 2003-04-15 Robert J. Dinerstein 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors
KR0130883Y1 (ko) * 1994-02-02 1998-12-15 김광호 컴퓨터의 하드 디스크 드라이버 착탈장치
KR20040100835A (ko) 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
EP1632281B1 (en) 2003-12-15 2011-09-14 Rohm And Haas Company Process for absorbing hydrophobic substances in polymers having an hollow structure
WO2006010379A1 (en) 2004-07-29 2006-02-02 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives as immunosuppressive agents
CA2602474C (en) 2005-03-23 2014-06-10 Actelion Pharmaceuticals Ltd Hydrogenated benzo (c) thiophene derivatives as immunomodulators
EP1863475B1 (en) 2005-03-23 2011-09-07 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
AU2006260573A1 (en) 2005-06-24 2006-12-28 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives
WO2007032591A1 (en) * 2005-09-13 2007-03-22 Industry-Academic Cooperation Foundation, Yeungnam University Composition comprising 1-furan-2-yl-3-pyridin-2-yl-pr0pen0ne having anti-angiogenic activity and cancer growth inhibitory activity
KR100779610B1 (ko) * 2005-09-13 2007-11-28 영남대학교 산학협력단 1-퓨란-2-일-3-피리딘-2-일-프로페논을 함유하는혈관신생으로 인한 질환 및 암질환의 예방 또는 치료용약학조성물
AR057894A1 (es) 2005-11-23 2007-12-26 Actelion Pharmaceuticals Ltd Derivados de tiofeno
DE602007003074D1 (de) 2006-01-24 2009-12-17 Actelion Pharmaceuticals Ltd Neue pyrinderivate
AR061841A1 (es) 2006-09-07 2008-09-24 Actelion Pharmaceuticals Ltd Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores.
AR062683A1 (es) 2006-09-07 2008-11-26 Actelion Pharmaceuticals Ltd Compuestos derivados de piridin-4-ilo, composicion farmaceutica que los contiene, y uso de los mismos en la preparacion de medicamentos
DK2069335T3 (da) 2006-09-08 2013-02-18 Actelion Pharmaceuticals Ltd Pyridin-3-ylderivater som immunomoduleringsmidler
EP2125797B1 (en) 2007-03-16 2014-01-15 Actelion Pharmaceuticals Ltd. Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
EP2252609B1 (en) 2008-03-07 2013-04-17 Actelion Pharmaceuticals Ltd. Pyridin-2-yl derivatives as immunomodulating agents
SG178042A1 (en) 2009-07-16 2012-03-29 Actelion Pharmaceuticals Ltd Pyridin-4-yl derivatives
US20130079348A1 (en) * 2010-03-03 2013-03-28 Calcimedica, Inc. Compounds that modulate intracellular calcium
SI2665720T1 (sl) 2011-01-19 2015-08-31 Actelion Pharmaceuticals Ltd. Derivati 2-metoksi-piridin-4-ila
JP2014100171A (ja) * 2012-11-16 2014-06-05 Hayashi Bussan Co Ltd 商品落下防止具
US10385043B2 (en) 2015-05-20 2019-08-20 Idorsia Pharmaceuticals Ltd Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409424A (en) * 1966-03-01 1968-11-05 Ethyl Corp Propynones as defoliants
FR2081591A1 (en) * 1970-03-27 1971-12-10 Unicler 2, 4-dimethoxyphenyl beta-pyrid-4-ylvinyl ketone - for treating capillary fragility and permeability
BE789099A (fr) * 1971-09-22 1973-03-21 Boehringer Sohn Ingelheim Nouveaux derives de la pyridine et procede pour les fabriquer
FR2387956A1 (fr) * 1977-04-20 1978-11-17 Unicler Derives de la pyridine et leur preparation
US4582836A (en) * 1985-01-09 1986-04-15 Mcneilab, Inc. Octahydroindolizine compounds useful as analgesics
DK49688A (da) * 1987-03-20 1988-09-21 Hoffmann La Roche Propiolophenonderivater

Also Published As

Publication number Publication date
IE913300A1 (en) 1992-02-25
JP3031766B2 (ja) 2000-04-10
IL99515A0 (en) 1992-08-18
FI914409A0 (fi) 1991-09-19
KR920006316A (ko) 1992-04-27
NO913684L (no) 1992-03-23
CA2051494C (en) 2006-03-14
ES2106042T3 (es) 1997-11-01
ZA917371B (en) 1992-06-24
TW205548B (fi) 1993-05-11
PT99011A (pt) 1992-08-31
AU653957B2 (en) 1994-10-20
NO913684D0 (no) 1991-09-19
JPH06271540A (ja) 1994-09-27
HU913010D0 (en) 1992-01-28
AU8452991A (en) 1992-03-26
EP0476646B1 (en) 1997-06-04
DE69126392T2 (de) 1998-01-22
KR100198040B1 (ko) 1999-06-15
HUT59099A (en) 1992-04-28
CN1063685A (zh) 1992-08-19
NZ239864A (en) 1994-05-26
FI914409A7 (fi) 1992-03-21
US5500429A (en) 1996-03-19
DE69126392D1 (de) 1997-07-10
ATE154011T1 (de) 1997-06-15
CA2051494A1 (en) 1992-03-21
EP0476646A1 (en) 1992-03-25

Similar Documents

Publication Publication Date Title
FI921344L (fi) Utfaellt kalciumkarbonat.
DE69112037D1 (de) Waferträger.
FI910791A0 (fi) Oeverfoeringssystem foer digiterade televisionsbilder.
FI923286A0 (fi) Kelateringsaemnen.
FI906448A0 (fi) Andningsmask.
FI914409L (fi) Kalciumupptagande inhibitorer.
DE69111876D1 (de) Ophthalmometer.
FI86244B (fi) Bakugn-spisugnkombination.
FI914438A0 (fi) Skyddsanordning foer valsnyp.
DE59104521D1 (de) Polkern.
FI914408L (fi) Kalciumupptagande inhibitorer.
DE69100071D1 (de) Kaefigmutter.
FI900062A0 (fi) Spelanordning.
FI914410L (fi) Kalciumupptagande inhibitorer.
ATE124392T1 (de) 8-sulfamylmethylen-2-aminotetraline.
DE59103525D1 (de) Honmachine.
DE69104797D1 (de) 2-Substituierte-1-Hydroxyindole.
FI900061A0 (fi) Spelanordning.
FI924364A0 (fi) Ogiftigt eldslaeckningsmedel.
FI903311A7 (fi) Stroemuttagningsanordning foer en ledningskanal.
DE59100113D1 (de) Rollcontainer.
NO901750D0 (no) Kalk/gjoedselblander.
ES1013726Y (es) Canal-moldura salvacables.
ES1014023Y (es) Traca pirotecnica.
ES1014804Y (es) Auto-caravana independizable.